Michael H DeGroote sold $290k of CBZ
director at CBIZ, Inc.. 8,362 shares at an average of $34.72, traded Oct 14, 2021, filed Mar 31, 2025.
Score components
- +15RoleDirector
- +14Trade size$290k at market
- 0Share of holdings soldSold 6.3% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-25-010676, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 14, 2021 | SOpen-market sale Common Stock | -8,362 | $34.72 | $290k | 124,592 | Mar 31, 2025 |
Related signals
Other insiders at CBIZ, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 37Weak | CBIZ, Inc. | Ware H Grove C.F.O. | $283k 4,029 shares | -1% | |
| 45Moderate | CBIZ, Inc. | Benaree Pratt Wiley director | $468k 6,526 shares | -14% | |
| 34Weak | CBZbuy CBIZ, Inc. | Rodney A Young director | $76k 1,000 shares | +34% | |
| 35Weak | CBZsell CBIZ, Inc. | Ware H Grove C.F.O. | $644k 8,143 shares | -3% | |
| 34Weak | CBZbuy CBIZ, Inc. | Rodney A Young director | $78k 1,000 shares | +51% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.